At the 6th Epigenomics of Common Diseases conference the Wellcome Genome Campus will bring together leading scientists from the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving area. The event will commence on October 1 – 4, 2016 in Hinxton, United Kingdom.
Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale, breadth and availability of epigenomic reference data. In addition, novel developments such as single cell analysis and gene editing present exciting new opportunities. Associations between epigenetic variation, a variety of risk factors and the development of many diseases continue to emerge but causality has, in many instances, not yet been established.
This meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease.
- Anne Ferguson-Smith – University of Cambridge, UK
- Oliver Rando UMass – Medical School, USA
- Schahram Akbarian – Icahn School of Medicine at Mount Sinai, USA
- Stephan Beck – UCL Cancer Institute, UK
- John Chambers – Imperial College London, UK
- Bill Cookson – Imperial College London, UK
- Manel Esteller – IDIBELL, Spain
- Daniele Fallin – Johns Hopkins Bloomberg School of Public Health, USA
- Andre Fischer – Georg-August-University, Gottingen, Germany
- Anna Gloyn – University of Oxford, UK
- Ivo Gut – CNAG-CRG, Spain
- Petra Hajkova – MRC Clinical Sciences Centre, UK
- Peter Jones – Van Andel Research Institute, USA
- David Katz – Emory University, USA
- John Marioni – EMBL-EBI, UK
- Stefan Mundlos – Charité Universitätsmedizin Berlin, Germany
- John Pospisilik – Max Planck Institute of Immunobiology and Epigenetics, Germany
- Wolf Reik – Babraham Institute, UK
- David Ruff – Fluidigm Corporation, USA
- Julian Sale – MRC Laboratory of Molecular Biology, UK
- Nicole Soranzo – Wellcome Trust Sanger Institute, UK
- Francois Spitz — Institut Pasteur, France
We welcome abstracts from all areas relevant to the main themes of the meeting, for both oral and poster presentations. Several oral presentations will be chosen from the abstracts submitted.
Please register prior to submitting your abstract. Please note: abstracts will only be considered from registered delegates.
The scientific programme committee will assess your abstract after the deadline has passed and you will be notified whether you have been selected for an oral or poster presentation.
- Epigenomics of disease
- Epigenetics in neuro-psychiatric disorders
- Cancer epigenetics
- Epigenetics of ageing
- Nutritional epigenetics
- Trans-generational epigenetic inheritance
- Computational epigenomics
- Population epigenetics
- Clinical epigenetics
- Single cell epigenetics
- Informatics and technology
A limited number of registration bursaries are available for PhD students to attend this conference (up to 50% of the registration fee) from Wellcome Genome Campus Scientific Conferences.
The following documents will need to be provided:
- Abstract, CV
- Covering letter
- Letter from supervisor
To apply, please contact the conference organiser. Bursary deadline: 6 September 2016
Scientific programme committee
- Edith Heard – Institut Curie, France
- Doug Higgs – University of Oxford, UK
- Caroline Relton – University of Bristol, UK
- Art Petronis – University of Toronto, Canada
- Laura Hubbard – Wellcome Genome Campus, UK